Boston – September 22, 2026 -- Viva-Thera has nominated a preclinical candidate targeting the membrane-proximal external region (MPER) of HIV-1 gp41, completing discovery and optimization in seven months through a partnership with AI drug-design firm XtalPi (HKEX: 2228). The biotech, incubated and backed by XtalPi as a strategic shareholder, made its public debut disclosing progress across four HIV modalities: vaccines, long-acting small molecules, gene therapy and cell therapy.

Hefei – September 22, 2026 -- Pylontech (688063:SH) began mass production of its 588Ah and 601Ah prismatic LFP cells for utility-scale energy storage at its Hefei manufacturing base on September 21, with more than 100MWh already produced.

Guangzhou – September 22, 2026 -- The 140th China Import and Export Fair, known as the Canton Fair, will run from October 15 to November 4, 2026, with more than 220,000 overseas buyers from 197 countries and regions already pre-registered, nearly 80% of them professional buyers.

Anyang – September 22, 2026 -- Anyang Indorama Gases Co., Ltd. has signed an RMB 2.4 billion (c. US$358 million) long-term loan facility with five banks to fund a Phase II fertilizer capacity expansion in Anyang City, Henan Province, China.

Suzhou – September 22, 2026 -- Boomray Pharmaceuticals Co., Ltd. has signed an exclusive global license agreement with Novartis Pharma AG for an undisclosed preclinical radioligand therapy (RLT) asset, with total deal value reaching up to USD 900 million.

Hangzhou, China – September 21, 2026 -- A joint survey by asmag.com and Hikvision found that 38.2% of video security professionals call storage cost or capacity a "major challenge," while another 43.2% rate it "moderate," together accounting for 81.4% of respondents.

Jinan – September 21, 2026 -- Bestzyme, a synthetic biology unit of GenScript Biotech, has completed what it calls the world's first dedicated, automated smart production line for sweet proteins at its Jinan facility, integrating R&D, mass production and application for the ingredient category for the first time globally.

Hong Kong – September 21, 2026 -- Akeso, Inc. (9926.HK) will present nearly 30 clinical studies of its bispecific antibodies at the European Society for Medical Oncology (ESMO) Congress in Madrid on October 23-27, 2026, including a Late-Breaking Abstract selected for the Presidential Symposium.

Jiangmen, China – September 21, 2026 -- Jiangmen Meixin Comb Brush Machinery Co., Ltd. is marking its 38th year of operation, having built a client base spanning Germany, the UK, Turkey, Brazil, Peru and Kenya, alongside broader market share across Asia, the Middle East and South America.

Beijing – September 21, 2026 -- T-MAXIMUM Pharmaceutical reported that two of three evaluable patients with refractory brain metastases from lung cancer achieved partial responses with roughly 80% tumor shrinkage after treatment with its allogeneic B7-H3-targeted CAR-T therapy, MT027, according to early data presented at the IASLC World Conference on Lung Cancer (WCLC 2026) in Seoul.